Is the Galleri multi-cancer blood test worth it? A doctor explains real-world performance data and explains why no major ...

Telehealth company Hims & Hers has added Grail’s blood cancer test Galleri to its offerings as the medtech has now sent off ...

Chair of powerful parliamentary committee writes to Health Secretary Wes Streeting backing Mirror campaign and demanding action on spinal muscular atrophy (SMA) ...

The Philippine Health Insurance Corp. (PhilHealth) is pivoting from a purely curative approach to a preventive healthcare model with the launch of its “Yakap” program, an official announced Monday ...

Comprehensive biomarker testing is crucial for NSCLC treatment, yet disparities exist between academic and community settings ...

A newer type of prostate cancer scan called 64 Cu-SAR-bisPSMA found more than twice as many cancer spots as a commonly used PSMA PET scan in men whose prostate-specific antigen (PSA) was rising after ...

Person-to-person transmissions of hepatitis A have occurred across the United States and many are affecting gay and bisexual men. Hepatitis A outbreaks among MSM have been reported frequently despite ...

Cellares has joined forces with the Stanford Center for Definitive and Curative Medicine (CDCM) and Stanford Innovative ...

The Director of the National Centre of Excellence for Sickle Cell Disease Research and Training, Prof. Obiageli Nnodu, said ...

In a significant move towards enhancing cancer detection and treatment, telehealth company Hims & Hers has announced the addition of Grail's Galleri multi-cancer blood test to its extensive digital ...

Cellares, the first Integrated Development and Manufacturing Organization (IDMO), today announced a collaboration with the Stanford Center for Definitive and Curative Medicine (CDCM) and Stanford ...

Despite groundbreaking research, many cell and gene therapies do not make it all the way to the patients. Researchers and clinicians in Lund have now presented a new model for cooperation that will ...